Related Experiment Video
Updated: May 9, 2026
11:23
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Pseudokinase drug intervention: a potentially poisoned chalice
Jeroen Claus1, Angus J M Cameron, Peter J Parker
1Cancer Research UK, London Research Institute, Lincoln's Inn Fields, London WC2A 3LY, UK. jeroen.claus@cancer.org.uk
Biochemical Society Transactions
|July 19, 2013
Summary
Pseudokinases, though catalytically impaired, show kinase-like properties, including ATP binding. Stabilizing specific conformations via ATP or drug binding impacts their potential as drug targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Pseudokinases are catalytically impaired kinome components.
- They share unexpected properties with active kinases.
- ATP binding and some activity are preserved in many pseudokinases.
Purpose of the Study:
- To explore the implications of stabilizing specific conformations in pseudokinases.
- To assess the dual impact on pseudokinase druggability.
- To highlight pseudokinases as potential drug targets.
Main Methods:
- Review of existing literature on pseudokinases and active kinases.
- Analysis of nucleotide-binding pocket interactions.
- Discussion of conformational stabilization strategies.
Main Results:
- Pseudokinases retain significant functional similarities to active kinases.
- ATP and drug binding can stabilize conformations in the nucleotide-binding pocket.
- This stabilization affects protein activity and interactions.
Conclusions:
- Pseudokinases represent promising targets for therapeutic intervention.
- Understanding conformational stabilization is key to optimizing pseudokinase-targeted drugs.
- Targeting specific conformations offers dual potential for modulating pseudokinase function.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:14Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...